Abstract

Understanding the underlying mechanisms leading to progressive muscle pathologies in spastic Cerebral Palsy remains a challenging field of research. Furthermore, Botulinum Neurotoxin-A (BoNT-A) is a frequent intervention to treat spasticity in CP but its effects on neuromuscular properties are not yet fully explored. High-density Electromyographic (HD-EMG) data have been collected before and after BoNT-A injections from children aged 5–15 years during isometric contractions of the ankle joint together with torque output, clinical assessments and demographic details. Data collected from a total of 13 children with and 29 children without spastic CP allow for between-group comparisons and are made available using Mendeley Data (https://doi.org/10.17632/3sbptrk54c.2 and https://doi.org/10.17632/3b98g5fyff.1).

Highlights

  • High-density electromyographic data during isometric contractions of the ankle joint in children with cerebral palsy pre and post Botulinum Neurotoxin-A (BoNT-A) treatment

  • Exclusion criteria for the CP group included severe cognitive or visual impairments interfering with the ability to cooperate with the experimental protocol, concomitant neurological diseases, BoNT-A injection within the previous 4 months, neurosurgical and lower-limb orthopaedics procedures within the previous 12-months, previous selective dorsal rhizotomy and/or intrathecal baclofen treatment

  • Individuals recruited for the TD group were gender- and age-matched within ±12-months to children in the CP group

Read more

Summary

Participants

Inclusion criteria for the CP group included spasticity affecting the lower limb requiring BoNT-A treatment. Children in the TD group were required to be healthy without neurosurgical or lower-limb orthopaedics procedures within the 12-months prior to participation. All participants and their parents or legal guardian provided written informed assent/consent and the measurements were conducted following the guidelines outlined by the Southern Health and Disability Ethics Committee, New Zealand (HDEC; Ethics reference: 17/STH/215). Individuals recruited for the TD group were gender- and age-matched within ±12-months to children in the CP group. Demographic details (age, gender, height, weight, BMI and body side assessed) of all participants can be obtained from the data available with Mendeley Data [3,4]

Clinical data
Experimental protocol
BoNT-A injection procedure
Data pre-processing
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.